Exscientia Ltd Adr Stock Market Capitalization
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Exscientia's long-term financial health and intrinsic value.
Exscientia |
Exscientia Ltd ADR Company Market Capitalization Analysis
Exscientia's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Exscientia Market Capitalization | 633.18 M |
Most of Exscientia's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Exscientia Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of Exscientia Ltd ADR is about 633.18 M. This is 95.11% lower than that of the Biotechnology sector and 86.64% lower than that of the Health Care industry. The market capitalization for all United States stocks is 96.67% higher than that of the company.
Exscientia Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Exscientia's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Exscientia could also be used in its relative valuation, which is a method of valuing Exscientia by comparing valuation metrics of similar companies.Exscientia is currently under evaluation in market capitalization category among its peers.
Exscientia Fundamentals
Return On Equity | -0.46 | |||
Return On Asset | -0.21 | |||
Operating Margin | (10.66) % | |||
Current Valuation | 346.92 M | |||
Shares Outstanding | 130.82 M | |||
Shares Owned By Insiders | 25.90 % | |||
Shares Owned By Institutions | 20.80 % | |||
Number Of Shares Shorted | 2.81 M | |||
Price To Book | 1.95 X | |||
Price To Sales | 37.10 X | |||
Revenue | 20.08 M | |||
Gross Profit | 10.25 M | |||
EBITDA | (145.45 M) | |||
Net Income | (145.96 M) | |||
Cash And Equivalents | 601.89 M | |||
Cash Per Share | 4.91 X | |||
Total Debt | 18.92 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 9.08 X | |||
Book Value Per Share | 1.95 X | |||
Cash Flow From Operations | (117.6 M) | |||
Short Ratio | 5.77 X | |||
Earnings Per Share | (1.51) X | |||
Price To Earnings To Growth | 0.10 X | |||
Target Price | 4.35 | |||
Number Of Employees | 483 | |||
Beta | 0.84 | |||
Market Capitalization | 633.18 M | |||
Total Asset | 510.72 M | |||
Retained Earnings | (110.47 M) | |||
Working Capital | 339.87 M | |||
Net Asset | 510.72 M |
Currently Active Assets on Macroaxis
USOI | Credit Suisse X Links | |
ULTY | Tidal Trust II | |
CONY | YieldMax N Option | |
BCAT | BlackRock Capital Allocation | |
PDI | Pimco Dynamic Income |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Exscientia Stock
If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |